Makowski G S, Ramsby M L
Department of Laboratory Medicine, University of Connecticut Health Center, Farmington 06030, USA.
Biochem Mol Biol Int. 1998 Dec;46(5):1043-53. doi: 10.1080/15216549800204592.
Three constitutive gelatinases in human plasma were identified and characterized relative to known matrix metalloproteinase (MMP) gelatinases: MMP-2 (fibroblast 72-kDa) and MMP-9 (neutrophil 92-, 130-, and 225-kDa). Substrate gel electrophoresis (gelatin zymography) revealed an apparent Mw of 78-, 82-, and 89-kDa for these gelatinases. Densitometry revealed that MMP-9 and MMP-2 were highly calcium sensitive requiring 50-150 microM and 500 microM calcium for half-maximal activity, respectively. Of the new gelatinases, only the 89-kDa form demonstrated slight calcium activation. The three gelatinases were unaffected by known MMP inhibitors: EDTA (5 mM), 1,10-phenanthroline (2 mM), and pepstatin (18 microM). Serine and thiol protease inhibitors (leupeptin, aprotinin, PMSF, TLCK, TPCK, antichymostatin, antipain) were also ineffective. Solution-phase IEF revealed that the 78- and 82-kDa forms focused at neutral pI 6.72-7.95 whereas the 89-kDa focused at an acidic pI 4.89-5.18 (similar to neutrophil and fibroblast forms). The data indicate that these gelatinases are not MMPs or partially activated MMPs. Their role in normal and pathological conditions is not known.
已在人血浆中鉴定出三种组成型明胶酶,并相对于已知的基质金属蛋白酶(MMP)明胶酶(MMP-2(成纤维细胞72 kDa)和MMP-9(中性粒细胞92 kDa、130 kDa和225 kDa))对其进行了表征。底物凝胶电泳(明胶酶谱法)显示这些明胶酶的表观分子量为78 kDa、82 kDa和89 kDa。光密度测定显示,MMP-9和MMP-2对钙高度敏感,分别需要50 - 150 μM和500 μM钙才能达到最大活性的一半。在新的明胶酶中,只有89 kDa的形式表现出轻微的钙激活。这三种明胶酶不受已知的MMP抑制剂(5 mM乙二胺四乙酸(EDTA)、2 mM 1,10 - 菲咯啉和18 μM胃蛋白酶抑制剂)的影响。丝氨酸和巯基蛋白酶抑制剂(亮抑酶肽、抑肽酶、苯甲基磺酰氟(PMSF)、甲苯磺酰-L-赖氨酸氯甲基酮(TLCK)、甲苯磺酰苯丙氨酸氯甲基酮(TPCK)、抗糜蛋白酶抑制素、抗蛋白酶)也无效。溶液相等电聚焦电泳显示,78 kDa和82 kDa的形式聚焦在中性pH值6.72 - 7.95,而89 kDa的形式聚焦在酸性pH值4.89 - 5.18(类似于中性粒细胞和成纤维细胞形式)。数据表明这些明胶酶不是MMP或部分活化的MMP。它们在正常和病理条件下的作用尚不清楚。